Page last updated: 2024-08-23

staurosporine and incb-018424

staurosporine has been researched along with incb-018424 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Ciceri, P; Davis, MI; Herrgard, S; Hocker, M; Hunt, JP; Pallares, G; Treiber, DK; Wodicka, LM; Zarrinkar, PP1
Gao, Q; Huang, Y; Liang, X; Wang, B; Xu, W; Zang, J; Zhang, Y1
Gao, Q; Liang, X; Wang, B; Xu, W; Zang, J; Zhang, Y; Zhu, M1
Cao, J; Feng, Y; Jia, Y; Jiang, L; Liu, Y; Wang, X; Wang, Z; Yin, H1

Other Studies

4 other study(ies) available for staurosporine and incb-018424

ArticleYear
Comprehensive analysis of kinase inhibitor selectivity.
    Nature biotechnology, 2011, Oct-30, Volume: 29, Issue:11

    Topics: Catalysis; Drug Design; Enzyme Stability; High-Throughput Screening Assays; Humans; Protein Binding; Protein Kinase Inhibitors; Protein Kinases; Proteomics; Signal Transduction; Substrate Specificity

2011
Design, synthesis and preliminary biological evaluation of 4-aminopyrazole derivatives as novel and potent JAKs inhibitors.
    Bioorganic & medicinal chemistry, 2016, 06-15, Volume: 24, Issue:12

    Topics: Antineoplastic Agents; Drug Design; HeLa Cells; Humans; Janus Kinase 2; Janus Kinases; Molecular Docking Simulation; Phosphorylation; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines

2016
Design, Synthesis, and Antitumor Evaluation of 4-Amino-(1
    ACS medicinal chemistry letters, 2016, Oct-13, Volume: 7, Issue:10

    Topics:

2016
Inhibition of human UDP-glucuronosyltransferase enzymes by midostaurin and ruxolitinib: implications for drug-drug interactions.
    Biopharmaceutics & drug disposition, 2020, Volume: 41, Issue:6

    Topics: Antineoplastic Agents; Drug Interactions; Glucuronosyltransferase; Humans; Isoenzymes; Nitriles; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Recombinant Proteins; Staurosporine

2020